AlphaFold2 Rapid Drug Discovery Vision Break Boundaries

Nuclera wants to use Google DeepMind to expedite the drug discovery process &Vertex AI’s AlphaFold2 The rapid protein access benchtop system from Nuclera, a biotechnology company based in the US and the UK

The structural biology and drug development industries have been enthralled by AlphaFold2, a groundbreaking artificial intelligence tool that DeepMind published in 2021

Combining the technologies of Google and Nuclera offers drug developers a new integrated approach to enhance protein construct creation and speed up the drug discovery process

Drug development relies heavily on the accessibility of proteins for lab-based research, which is notoriously expensive and difficult to acquire, placing time and budget constraints on research potential

AlphaFold2 is an artificial intelligence (AI) model created by DeepMind that predicts the 3D structure of a protein based on its 1D amino acid sequence

Nuclera’s cloud-based software will use AlphaFold2, which runs on Google Cloud’s Vertex AI, as a key component to enhance the quality and obtainability of proteins

In order to create a scalable and resource-efficient AlphaFold pipeline, Nuclera will leverage the Vertex AI platform Additionally, the company will leverage other Google Cloud services to expose the pipeline via an API and link